- N/T
Greenheart CBD
CBD
We lack of accurate trading data.
This could be attributed to several reasons, including limited exchange liquidity or delisting. Or might be due unable to provide support for exchanges where this asset is currently tradable.
Investors
X Followers
Greenheart CBD (CBD) Fundraising & Investors
Greenheart CBD Fundraising Rounds
Tokens for Sale4.50 M
% of Total Supply3.00%
Pre-valuation
$15.00 MPlatform
BSCpad
InvestorsNo Investors found yet
ROI
--USD--BTC--ETHDistribution TypeTokens vested 12.5% weekly over an 8-week period
Tokens for Sale1.76 M
% of Total Supply1.17%
Pre-valuation
$11.25 MPlatform
BSCpad
InvestorsNo Investors found yet
ROI
--USD--BTC--ETHDistribution TypeTokens vested 25% monthly over a 4-month period
Tokens for Sale1.50 M
% of Total Supply1.00%
Pre-valuation
$15.00 MPlatform
Zendit
InvestorsNo Investors found yet
ROI
--USD--BTC--ETHDistribution TypeTokens vested 12.5% weekly over an 8-week period
Tokens for Sale6.67 M
% of Total Supply4.44%
Pre-valuation
$11.25 MPlatform
Launchpool
InvestorsNo Investors found yet
ROI
--USD--BTC--ETHDistribution Type25% per month after a 1-month cliff
Tokens for Sale48.00 M
% of Total Supply32.00%
Pre-valuation
$11.25 MPlatform--
InvestorsAlphabit FundLead
ROI
--USD--BTC--ETHDistribution TypeTokens vested 25% monthly over a 4-month period
Score
DetailsNeutral Interest
- Hype
- Not rated
- Risk
- Not rated
- ROI
- Not rated
Fundraising Statistics
- Tokens Sold
- 62.43 M
- Funds Raised
- $4.83 M
Total for Sale %41.62%
Token Allocation
Private Sale32.00%
Team20.00%
Staking Rewards10.00%
Ecosystem Expansion10.00%
Reserves8.39%
Floating Liquidity5.00%
Partners & Advisors5.00%
Private Sale (IDO on Launchpool)4.44%
Public Sale (IDO on BSCPad)3.00%
Private Sale (IDO on BSCPad)1.17%
Public Sale (IDO on ZENDIT)1.00%
Greenheart CBD Investors
Greenheart CBD (CBD) Fundraising & Investors
Important Note
All information including our Interest Level rating, is provided merely for informational purposes. DropsTab & ICO Drops does not provide investment advice.